2026年9月4日，英派药业-B（股票代码：07630）发布2026年8月股份变动月报表。公告显示，截至2026年8月31日，公司注册股本为人民币282,461,530元，股票类型为普通股H股，面值人民币1元。本月初和月末的已发行股份数均为282,461,530股，库藏股份为0股，股本总数未发生变化。
公司同时披露，报告期内未进行新的股份发行、购回、注销或库藏股变动，也不存在任何股份期权、权证或可换股票据的行使或失效情形。截至期末，公司符合香港联交所相关上市规则的最低公众持股量要求。
公告由执行董事兼首席执行官蔡遂雄签署，公司重申将继续严格遵守香港联交所《上市规则》及相关法律法规的各项规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.